CHICAGO — Edith Mitchell, MD, FACP, clinical professor of Medicine and Medical Oncology at Thomas Jefferson University Hospital in Philadelphia, discusses a number of trials involving ziv-aflibercept (Valtrap, Sanofi Aventis US) from ASCO 2013. She says that the drug has been linked to encouraging results, and may soon be an attractive treatment option in patients with metastatic colorectal cancer.
More »